Global Colorectal Cancer Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

Table of Contents

1 Market Overview
    1.1 Colorectal Cancer Drugs Introduction
    1.2 Market Analysis 
        1.2.1 Overview: Global Colorectal Cancer Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
        1.2.2 Vascular Endothelial Growth Factor (VEGF) Inhibitors
        1.2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitors
        1.2.4 Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors
        1.2.5 BRAF or MEK Inhibitors
        1.2.6 Tyrosine Kinase (TKI) Inhibitors
        1.2.7 Immunomodulators
    1.3 Market Analysis 
        1.3.1 Overview: Global Colorectal Cancer Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
        1.3.2 Radiotherapy
        1.3.3 Chemotherapy
    1.4 Global Colorectal Cancer Drugs Market Size & Forecast
        1.4.1 Global Colorectal Cancer Drugs Sales in Value (2016-2026))
        1.4.2 Global Colorectal Cancer Drugs Sales in Volume (2016-2026)
        1.4.3 Global Colorectal Cancer Drugs Price by Type (2016-2026) & (USD/Kg)
    1.5 Global Colorectal Cancer Drugs Production Capacity Analysis
        1.5.1 Global Colorectal Cancer Drugs Total Production Capacity (2016-2026)
        1.5.2 Global Colorectal Cancer Drugs Production Capacity by Geographic Region
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Colorectal Cancer Drugs Market Drivers
        1.6.2 Colorectal Cancer Drugs Market Restraints
        1.6.3 Colorectal Cancer Drugs Trends Analysis
2 Manufacturers Profiles
    2.1 AB Science
        2.1.1 AB Science Details
        2.1.2 AB Science Major Business
        2.1.3 AB Science Colorectal Cancer Drugs Product and Services
        2.1.4 AB Science Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.2 Amgen
        2.2.1 Amgen Details
        2.2.2 Amgen Major Business
        2.2.3 Amgen Colorectal Cancer Drugs Product and Services
        2.2.4 Amgen Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.3 Array BioPharma
        2.3.1 Array BioPharma Details
        2.3.2 Array BioPharma Major Business
        2.3.3 Array BioPharma Colorectal Cancer Drugs Product and Services
        2.3.4 Array BioPharma Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.4 Bayer
        2.4.1 Bayer Details
        2.4.2 Bayer Major Business
        2.4.3 Bayer Colorectal Cancer Drugs Product and Services
        2.4.4 Bayer Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.5 Boehringer Ingelheim
        2.5.1 Boehringer Ingelheim Details
        2.5.2 Boehringer Ingelheim Major Business
        2.5.3 Boehringer Ingelheim Colorectal Cancer Drugs Product and Services
        2.5.4 Boehringer Ingelheim Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.6 Bristol-Myers Squibb
        2.6.1 Bristol-Myers Squibb Details
        2.6.2 Bristol-Myers Squibb Major Business
        2.6.3 Bristol-Myers Squibb Colorectal Cancer Drugs Product and Services
        2.6.4 Bristol-Myers Squibb Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.7 Elli Lilly
        2.7.1 Elli Lilly Details
        2.7.2 Elli Lilly Major Business
        2.7.3 Elli Lilly Colorectal Cancer Drugs Product and Services
        2.7.4 Elli Lilly Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.8 Roch
        2.8.1 Roch Details
        2.8.2 Roch Major Business
        2.8.3 Roch Colorectal Cancer Drugs Product and Services
        2.8.4 Roch Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.9 Hutchison MediPharma
        2.9.1 Hutchison MediPharma Details
        2.9.2 Hutchison MediPharma Major Business
        2.9.3 Hutchison MediPharma Colorectal Cancer Drugs Product and Services
        2.9.4 Hutchison MediPharma Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.10 Merck & Co., Inc.
        2.10.1 Merck & Co., Inc. Details
        2.10.2 Merck & Co., Inc. Major Business
        2.10.3 Merck & Co., Inc. Colorectal Cancer Drugs Product and Services
        2.10.4 Merck & Co., Inc. Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.11 Mologen
        2.11.1 Mologen Details
        2.11.2 Mologen Major Business
        2.11.3 Mologen Colorectal Cancer Drugs Product and Services
        2.11.4 Mologen Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.12 Regeneron
        2.12.1 Regeneron Details
        2.12.2 Regeneron Major Business
        2.12.3 Regeneron Colorectal Cancer Drugs Product and Services
        2.12.4 Regeneron Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.13 Sanofi
        2.13.1 Sanofi Details
        2.13.2 Sanofi Major Business
        2.13.3 Sanofi Colorectal Cancer Drugs Product and Services
        2.13.4 Sanofi Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.14 Sumitomo Dainippon
        2.14.1 Sumitomo Dainippon Details
        2.14.2 Sumitomo Dainippon Major Business
        2.14.3 Sumitomo Dainippon Colorectal Cancer Drugs Product and Services
        2.14.4 Sumitomo Dainippon Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.15 Taiho Pharmaceutical
        2.15.1 Taiho Pharmaceutical Details
        2.15.2 Taiho Pharmaceutical Major Business
        2.15.3 Taiho Pharmaceutical Colorectal Cancer Drugs Product and Services
        2.15.4 Taiho Pharmaceutical Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
    2.16 Vaccinogen
        2.16.1 Vaccinogen Details
        2.16.2 Vaccinogen Major Business
        2.16.3 Vaccinogen Colorectal Cancer Drugs Product and Services
        2.16.4 Vaccinogen Colorectal Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Colorectal Cancer Drugs Sales by Manufacturer
    3.1 Global Colorectal Cancer Drugs Sales in Volume by Manufacturer (2019-2021e)
    3.2 Global Colorectal Cancer Drugs Revenue by Manufacturer (2019-2021e)
    3.3 Key Manufacturer Market Position in Colorectal Cancer Drugs
    3.4 Market Concentration Rate
        3.4.1 Top 3 Colorectal Cancer Drugs Manufacturer Market Share
        3.4.2 Top 6 Colorectal Cancer Drugs Manufacturer Market Share
    3.5 Global Colorectal Cancer Drugs Production Capacity by Company
    3.6 Manufacturer by Geography: Head Office and Colorectal Cancer Drugs Production Site
    3.7 New Entrant and Capacity Expansion Plans
    3.8 Mergers & Acquisitions
4 Market Analysis by Region
    4.1 Global Colorectal Cancer Drugs Market Size by Region
        4.1.1 Global Colorectal Cancer Drugs Sales in Volume by Region (2016-2026)
        4.1.2 Global Colorectal Cancer Drugs Revenue by Region (2016-2026)
    4.2 North America Colorectal Cancer Drugs Revenue (2016-2026)
    4.3 Europe Colorectal Cancer Drugs Revenue (2016-2026)
    4.4 Asia-Pacific Colorectal Cancer Drugs Revenue (2016-2026)
    4.5 South America Colorectal Cancer Drugs Revenue (2016-2026)
    4.6 Middle East and Africa Colorectal Cancer Drugs Revenue (2016-2026)
5 Market Segment by Type
    5.1 Global Colorectal Cancer Drugs Sales in Volume by Type (2016-2026)
    5.2 Global Colorectal Cancer Drugs Revenue by Type (2016-2026)
    5.3 Global Colorectal Cancer Drugs Price by Type (2016-2026)
6 Market Segment by Application
    6.1 Global Colorectal Cancer Drugs Sales in Volume by Application (2016-2026)
    6.2 Global Colorectal Cancer Drugs Revenue by Application (2016-2026)
    6.3 Global Colorectal Cancer Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
    7.1 North America Colorectal Cancer Drugs Sales by Type (2016-2026)
    7.2 North America Colorectal Cancer Drugs Sales by Application (2016-2026)
    7.3 North America Colorectal Cancer Drugs Market Size by Country
        7.3.1 North America Colorectal Cancer Drugs Sales in Volume by Country (2016-2026)
        7.3.2 North America Colorectal Cancer Drugs Revenue by Country (2016-2026)
        7.3.3 United States Market Size and Forecast (2016-2026)
        7.3.4 Canada Market Size and Forecast (2016-2026)
        7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
    8.1 Europe Colorectal Cancer Drugs Sales by Type (2016-2026)
    8.2 Europe Colorectal Cancer Drugs Sales by Application (2016-2026)
    8.3 Europe Colorectal Cancer Drugs Market Size by Country
        8.3.1 Europe Colorectal Cancer Drugs Sales in Volume by Country (2016-2026)
        8.3.2 Europe Colorectal Cancer Drugs Revenue by Country (2016-2026)
        8.3.3 Germany Market Size and Forecast (2016-2026)
        8.3.4 France Market Size and Forecast (2016-2026)
        8.3.5 United Kingdom Market Size and Forecast (2016-2026)
        8.3.6 Russia Market Size and Forecast (2016-2026)
        8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
    9.1 Asia-Pacific Colorectal Cancer Drugs Sales by Type (2016-2026)
    9.2 Asia-Pacific Colorectal Cancer Drugs Sales by Application (2016-2026)
    9.3 Asia-Pacific Colorectal Cancer Drugs Market Size by Region
        9.3.1 Asia-Pacific Colorectal Cancer Drugs Sales in Volume by Region (2016-2026)
        9.3.2 Asia-Pacific Colorectal Cancer Drugs Revenue by Region (2016-2026)
        9.3.3 China Market Size and Forecast (2016-2026)
        9.3.4 Japan Market Size and Forecast (2016-2026)
        9.3.5 Korea Market Size and Forecast (2016-2026)
        9.3.6 India Market Size and Forecast (2016-2026)
        9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
        9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
    10.1 South America Colorectal Cancer Drugs Sales by Type (2016-2026)
    10.2 South America Colorectal Cancer Drugs Sales by Application (2016-2026)
    10.3 South America Colorectal Cancer Drugs Market Size by Country
        10.3.1 South America Colorectal Cancer Drugs Sales in Volume by Country (2016-2026)
        10.3.2 South America Colorectal Cancer Drugs Revenue by Country (2016-2026)
        10.3.3 Brazil Market Size and Forecast (2016-2026)
        10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
    11.1 Middle East & Africa Colorectal Cancer Drugs Sales by Type (2016-2026)
    11.2 Middle East & Africa Colorectal Cancer Drugs Sales by Application (2016-2026)
    11.3 Middle East & Africa Colorectal Cancer Drugs Market Size by Country
        11.3.1 Middle East & Africa Colorectal Cancer Drugs Sales in Volume by Country (2016-2026)
        11.3.2 Middle East & Africa Colorectal Cancer Drugs Revenue by Country (2016-2026)
        11.3.3 Turkey Market Size and Forecast (2016-2026)
        11.3.4 Egypt Market Size and Forecast (2016-2026)
        11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
        11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
    12.1 Sales Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
    12.2 Colorectal Cancer Drugs Typical Distributors
    12.3 Colorectal Cancer Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer